Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease-Reference-Cited by-同舟云学术

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease

Published:2014-01-27 Issue:1 Volume:2 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Ceccom Johnatan,Loukh Najat,Lauwers-Cances Valérie,Touriol Christian,Nicaise Yvan,Gentil Catherine,Uro-Coste Emmanuelle,Pitson Stuart,Maurage Claude Alain,Duyckaerts Charles,Cuvillier Olivier,Delisle Marie-Bernadette

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/2051-5960-2-12.pdf

Reference56 articles.

1. Duyckaerts C, Delatour B, Potier MC: Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009, 118: 5–36.

2. Nelson PT, Alafuzoff I, Bigio EH, et al.: Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012, 71: 362–381.

3. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K: Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006, 112: 389–404.

4. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82: 239–259.

5. Thal DR, Rub U, Orantes M, Braak H: Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58: 1791–1800.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Sphingosine Kinase 1 Reduces Sphingosine-1-Phosphate and Exacerbates Amyloid-Beta-Induced Neuronal Cell Death in Mixed-Glial-Cell Culture;Neurology International;2024-07-04

2. SCG5 and MITF may be novel markers of copper metabolism immunorelevance in Alzheimer’s disease;Scientific Reports;2024-06-13

3. Alzheimer’s disease manifests abnormal sphingolipid metabolism;Frontiers in Aging Neuroscience;2024-05-07

4. Frontal Cortex Lipid Alterations During the Onset of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-16

5. Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies;Pharmacological Research;2024-04